BioSpace News Archive

Have you ever stopped yourself from applying for a position with a high profile, life sciences organization because you thought it wasn’t worth it?

Valeritas and its subsidiaries filed for Chapter 11 bankruptcy on February 9, 2020 in the District of Delaware. At the same time, Zealand entered into the definitive deal to buy the assets.

Renowned drug discovery leader to guide alliance formed to improve scientific exchange in UK drug discovery community

As public health leaders from around the world, including the U.S. Centers for Disease Control and Prevention, work to contain the spread of the 2019 Novel Coronavirus, a team at Regenstrief Institute, an international leader in health information technology, is providing help to track cases of the illness.

As a global specialized Contract Research Organization providing high-quality protein analytical services to support research, manufacturing and clinical development of native and recombinant proteins, Creative BioMart recently released Intracellular Cytokine Detection and Activity Assay to help explore new frontiers in biological science.

Summit Therapeutics plc announced that it achieved the first milestone under its license and collaboration agreement with Eurofarma Laboratórios SA.

Panthera, the newly launched independent clinical trial site management organisation, has opened its first site in Preston in the UK with a second site in North Manchester to open in March.

DIAN-TU-001 is a Phase II/III trial that tested two therapies compared to placebo, Genentech and Roche’s gantenerumab and Eli Lilly and Company’s solanezumab.

So far, this has only been demonstrated in mice, but the research shows that the underlying processes are conserved in humans.

Pan-Cancer Project discovers the causes of previously unexplained cancers, pin-points cancer-causing events, and zeros in on mechanisms of development